논문검색
Author Jun Hwa Hwang, M.D., Kyu Sik Kim, M.D., Yu Il Kim, M.D., Eun Joung Kim, B.A., Kyung Hwa Park, M.D., Gye Jung Cho, M.D., Jin Young Ju, M.D., Sung Chul Lim, M.D., Young Chul Kim, M.D., Kyung Ok Park, M.D., Jong Tae Park, M.D.1 and Sung-Ja Ahn, M.D.2
Place of duty Department of Internal Medicine, 1Forensic Medicine and 2Radiation Oncology, Research Institute of Medical Sciences Chonnam National University Medical School, Gwangju, Korea
Title Genetic Polymorphism of Epoxide Hydrolase and GSTM1 in Lung Cancer Susceptibility of Korean Population
Publicationinfo Cancer Research and Treatment 2003 Dec; 035(06): 483-488.
Key_word Lung neoplasm, Genetic polymorphism, Epoxide hydrolase, Glutathione S transferase
Full-Text
Abstract Purpose: Although 80∼90% of patients with lung cancer are smokers, only 11% of smokers develop lung cancer. Genetic susceptibility according to the polymorphism of the epoxide hydrolase (mEPHX) gene and homozygous deletion of GSTM1 (M1 subunit of Glutathione S transferase) was studied in this case control study.

Materials and Methods: Genomic DNA from 76 subjects with lung cancer (40 squamous cell carcinoma, 13 adenocarcinoma, 10 subtype undetermined non-small cell lung cancer, and 13 small cell lung carcinoma) and 62 age- matched controls were extracted from peripheral white blood cells. PCR and RFLP (restriction fragments length polymorphism) with restriction enzyme (RsaI) and automatic sequencing were used for mEPHX genotyping (T→C, Tyr113His) in exon 3 and (A→G, His139Arg) in exon 4. Looking for homozygous deletions of GSTM1, multiplex PCR with primers for the GSTM1 gene and coagulation factor V gene (as positive control) were performed.

Results: The age distribution between the cancer and control groups were similar (63.6⁑7.2 vs. 61.1⁑7.9 years). The lung cancer group, however, had more smokers (73.3%, 44/60) than the control group (21/54, 38.9%, p＜0.001). The rate of homozygous deletion of the GSTM1 gene was significantly higher in the lung cancer group (65.8%, 50/76) than in the control group (46.8%, 29/62, p＜0.05), causing the relative risk of GSTM1 deletion for lung cancer as 2.19 (95% CI : 1.10∼4.35, p=0.02). Among 118 subjects whose mEPHX gene polymorphisms were studied, 62 (52.5%) subjects showed genotypes with slow enzyme activity while 45 (38.1%) showed normal enzyme activity and 11 (9.3%) showed fast enzyme activity. There was no significant difference in the distribution of mEPHX gene polymorphisms between the two groups.

Conclusion: The homozygous deletion of the GSTM1 gene was associated with high lung cancer susceptibility, whereas the mEPHX genotype showed no significant connection with risk of lung cancer in a sample Korean population. (Cancer Research and Treatment 2003;35:483⁣488)